Earnings Summary

Abbott Laboratories’s revenue jumped 2.23% since last year same period to $9964Mn in the Q1 2024. On a quarterly growth basis, Abbott Laboratories has generated -2.7% fall in its revenue since last 3-months.

Abbott Laboratories’s net profit fell -7.06% since last year same period to $1225Mn in the Q1 2024. On a quarterly growth basis, Abbott Laboratories has generated -23.15% fall in its net profits since last 3-months.

Abbott Laboratories’s net profit margin fell -9.08% since last year same period to 12.29% in the Q1 2024. On a quarterly growth basis, Abbott Laboratories has generated -21.01% fall in its net profit margins since last 3-months.

Abbott Laboratories’s price-to-earnings ratio after this Q1 2024 earnings stands at 33.84.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a 9.09% jump from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.2.

Abbott Laboratories’s earning per share (EPS) jumped 5.56% since last year same period to 1.14 in the Q2 2024. This indicates that the Abbott Laboratories has generated 5.56% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.55 dividend per share during the earnings announcement for Q2 2024.